India Draft Guidance Aims at Better Control of Biologics During Transport, Storage
Distributors of biological products must maintain records of temperature monitoring data and check temperatures during transport and storage at defined intervals, according to a draft guidance by India’s Central Drugs Standard Control Organization (CDSCO).
Monitoring equipment should also be regularly checked and all temperature-related records maintained for the shelf-life of the product plus one year, the Sept. 17 draft states.
Moreover, storage facilities should be temperature-mapped to ensure uniformity across the area, with particular attention given to areas that are susceptible to fluctuations. An alarm system “shall be in place to provide alerts when there are deviations from predefined storage conditions,” according to the draft.
In the pharmaceutical industry, success means staying abreast of regulatory changes from Argentina to Zimbabwe. With a subscription to the International Pharmaceutical Regulatory Monitor, you will have the resource needed to keep you knowledgeable on a global scale. Subscribe today!
Come for this valuable opportunity to hear FDA officials discuss regulatory plans and objectives — and ask questions you need answered; learn from device industry experts, consultants and other experts with actionable tips and strategies you can take straight back to the office; and network with other professionals who understand your challenges; share war stories and insights over a drink. Register Today.Read More
The FDA's new enforcement plan makes one thing clear: Developing a successful CAPA program has never been more important. But creating an FDA-proof CAPA isn’t easy. If only you could pick the brain of someone who is coping successfully with CAPA — the best and the brightest, an industry leader who has devised programs, procedures and solutions that have put companies out in front with the FDA. Well, you can. Register today.Read More
The FDA’s cadre of freshly trained inspectors — many of whom come directly from industry — and increased focus on specialized inspections are making it harder than ever to predict the outcome of your next FDA inspection. Unless, of course, you have Surviving an FDA Inspection at your fingertips. If you could spend less than $400 to get your drug manufacturing facility fully prepared to face a tough inspection by the FDA, would you even hesitate? ... Of course not!